ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

WGS vs JNJ // DIVIDEND YIELD & FCF PAYOUT SAFETY

GeneDx Holdings Corp. (Class A) (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: WGS 2 — JNJ 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WGS VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC WGS JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 69.70% 67.90% +1.80 WGS /gross-margins <GO>
Return on Invested Capital (ROIC) -4.10% 25.50% -29.60 JNJ /roic <GO>
EV/EBITDA & P/E Valuation — 18.5x — TIE /valuation <GO>
Free Cash Flow Yield 0.67% 2.97% -2.30 JNJ /fcf-yield <GO>
Operating Margin -3.10% 34.70% -37.80 JNJ /operating-margins <GO>
Net Profit Margin -4.90% 28.50% -33.40 JNJ /net-margins <GO>
Revenue Growth (YoY) 40.00% 6.00% +34.00 WGS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.32 5.59 -2.27 JNJ /balance-sheet <GO>
Piotroski F-Score Quality 8/9 8/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 50.8 62.1 -11.30 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 23.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.12B $662.49B -$660.37B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR WGS REV JNJ REV WGS GROSS % JNJ GROSS % WGS FCF JNJ FCF
FY 2025 $427.5M $94.19B 69.7% 67.9% $14.3M $19.70B
FY 2024 $305.4M $88.82B 63.6% 69.1% -$34.0M $19.84B
FY 2023 $202.6M $85.16B — — -$180.1M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WGS // BETA —
JNJ // BETA 1.08